Approaches to defining the optimal dietary folate intake for cardiovascular health

Nutrition & Food Science

Volumn 97, Issue 6, 1997, Pages 215-217

  McDowell, Ian F w ^a   Ashfield Watt, Pauline ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Diet; Diseases; Health; Nutrition

Indexed keywords

EID: 84986047412     PISSN: 00346659     EISSN: None     Source Type: Journal    
DOI: 10.1108/00346659710180316     Document Type: Article

References (13)

1. Bellamy, M.F., Ramsey, M.W., Goodfellow, L., Brownlee, M., Gorman, S., McDowell, I.F.W. and Lewis, M.J. (1996), “Hyperhomocysteinemia and endothelial dysfunction with low B12/folate status”, Circulation, Vol. 94, pp. 1-462
2. Boushey, C.J., Shirley, S.A.A., Beresford, A.A., Omenn, G.S. and Motulsky, A.G. (1995), “A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes”, Journal of American Medical Association, Vol. 274, pp. 1049-57.
3. Bowen, D.J., Clark, Z., Whatley, S.D., McDowell, I.F.W. and Collins, P.W. (1997), “Factor V Leiden (G1691A) and thermolabile methylenetetrahydrofolate reductase (G677T): a single genetic test for the detection of both mutations using heteroduplex technology”, British Journal of Haematology, Vol. 97, supplement 1, p. 79.
4. Celermajer, D.S., Sorensen, K., Ryalls, M., Robinson, J., Thomas, O., Leonard, J.V. and Deanfield, J.E. (1993), “Impaired endothelial function occurs in systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents”, Journal American College of Cardiology, Vol. 22, pp. 854-8.
5. Frosst, P., Blom, H.J., Milos, P., Goyette, P., Shepperd, C.A. and Matthews, R.G. (1995), “A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase”, Nature Genetics, Vol. 10, pp. 111-3.
6. Goodfellow, J., Ramsey, M.W., Luddington, L.A., Jones, C.J.H., Coates, P.A. and Dunstan, F. (1996), “Endothelium and inelastic arteries: an early marker of vascular dysfucntion in non-insulin dependent diabetes”, British Medical Journal, Vol. 312, pp. 744-5.
7. Guttormsen, A.B., Ueland, P.M., Nesthus, I., Nygard, O., Schneede, S., Vollset, S.E. and Refsum, H. (1996), “Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> 40μmol/L)”, Journal of Clinical Investigation, Vol. 98, pp. 2174-83.
8. Harmon, D.L., Woodside, J.V., Yarnell, J.W.G., McMaster, D., Young, I.S. and McCrum, E.E. (1996), “The common ‘thermolabile’ variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia”, Quarterly Journal of Medicine, Vol. 89, pp. 571-7.
9. Henderson, A.H. (1991), “Endothelium in control”, British Heart Journal, Vol. 65, pp. 116-25.
10. Jacques, P., Bostom, A., Williams, R., Curtis Ellison, R., Eckfeldt, J. and Rosenberg, I. (1996), “Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations”, Circulation, Vol. 93, pp. 7-9.
11. McCully, K.S. (1996), “Homocysteine and vascular disease”, Nature Medicine, Vol. 2, pp. 386-9.
12. Ramsey, M.W., Goodfellow, J., Jones, C.J.H., Luddington, L.A., Lewis, M.J. and Henderson, A.H. (1995), “Endothelial control of arterial distensibility is impaired in chronic heart failure”, Circulation, Vol. 92, pp. 3212-9.
13. Selhub, J., Jacques, P.F., Wilson, P.W.F., Rush, D. and Rosenberg, I.H. (1993), “Vitamin status and intake as primary determinants of homocysteinemia in an elderly population”, Journal of American Medical Association, Vol. 270, pp. 2693-8.